- Filed
- Mar 24, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 14, 2025 | 9.24M sh |
| Rd Expense | FY 2024 · Dec 31, 2024 | $215.54K |
| Rd Expense restated | FY 2024 · Dec 31, 2023 | $210.23K |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 9.22M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2023 | $7.21K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$1.08M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $13.57M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.14M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $3.75M |
| Current Assets | FY 2024 · Dec 31, 2023 | $14.77M |
| Total Assets | FY 2024 · Dec 31, 2023 | $23.89M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.12 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.12 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $4.07M |
| Net Income | FY 2024 · Dec 31, 2023 | −$1.07M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$3.7M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2023 | $284.89K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $20.97M |